GCC
GILD icon

Game Creek Capital’s Gilead Sciences GILD Stock Holding History

Game Creek Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17,750
Closed -$1.37M – 59
2020
Q2 		$1.37M Buy
17,750
+4,000
+29% +$307K 1.12% 32
2020
Q1 		$1.03M Buy
+13,750
New +$950K 0.95% 31
2018
Q1 		– Sell
-5,000
Closed -$358K – 136
2017
Q4 		$358K Buy
+5,000
New +$380K 0.1% 155

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Game Creek Capital's GILD Position: Q3 2020 in Review

Game Creek Capital sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 17,750 shares — an estimated $1.37M sold.

Game Creek Capital first reported a position in GILD in Q4 2017 and held it in 3 quarters. The position peaked at $1.37M in Q2 2020. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Game Creek Capital reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Game Creek Capital sold 17,750 Gilead Sciences shares in Q3 2020, an estimated $1.37M.
  • Game Creek Capital first reported a position in Gilead Sciences in Q4 2017 and held it in 3 quarters.
  • Game Creek Capital's Gilead Sciences position peaked at $1.37M in Q2 2020.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Game Creek Capital's 13F filing for Q3 2020, filed 12 Nov 2020.